LEQEMBI Alzheimer’s Treatment Gets FDA Go Ahead
Phase 2 data showing a reduction in amyloid-beta plaques in early Alzheimer's patients is good enough for FDA to give it temporary approval under their Accelerated Approval pathway.
Test announcement
Announcement here about some event or update. Or maybe link to promoted article.
More reads
Military Veteran Deaths Went Up In 2020 As You'd Expect, But Less Than The General Population
Suicides and other mental health issues, as well as general deaths, went up during the pandemic in 2020 and veterans were not excluded. But they fared better than the general population, which is…
It's November 2019 - How Close Did We Get To Blade Runner?
It's November of 2019 which means that we have officially arrived at the opening of the science fiction cult classic "Blade Runner." Let's talk about what it got right.
Asperger Killed Disabled Kids For The Nazis
All of the people who joke they have Asperger's or are "on the spectrum" as an excuse for behavior they know is simply annoying or weird are probably going to want to stop. It's going to be a lot…